Overview / Abstract: |
Long-chain fatty acid oxidation disorders (LC-FAODs) are rare; however, these conditions continue to be associated with high mortality and suboptimal disease control. Reasons include: 1) a lack of agreement regarding LC-FAOD treatment, 2) a lack of published guidelines, 3) treatment nonadherence among patients, 4) confusion regarding how to assess and interpret LC-FAOD lab values, and 5) a need for more improved treatment options. A newer therapy, triheptanoin, is in late-stage development and has already demonstrated improved outcomes compared to conventional medium-chain triglyceride (MCT) treatment in clinical trials. This activity, Breaking Down Long-Chain Fatty Acid Oxidation Disorder Treatment: Review of Current Care and the Latest Advances, will help metabolic clinicians better assess and manage LC-FAOD and educate their patients to encourage adherence to treatment. |
Expiration |
Jul 15, 2021 |
Discipline(s) |
Dietetics / Dietitian CE, Physician CME |
Format |
Online, Webinar / Webcast / Video |
Credits / Hours |
1.0 |
Accreditation |
ACCME, ABIM MOC, CDR |
Presenters / Authors / Faculty |
Melanie Gillingham, PhD, RD Jerry Vockley, MD, PhD |
Activity Specialities / Related Topics |
Primary Care |
Sponsors / Supporters / Grant Providers |
This program is supported by an educational grant from Ultragenyx Pharmaceutical Inc. |
Keywords / Search Terms |
Rockpointe Free CME, free dietitian credit, dietitian, FAOD, LC_FAOD, long-chain fatty acid oxidation disorder, CDR, ABIM MOC, fatty acid oxidation disorder Free CE CME |